Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma-Reference-Cited by-同舟云学术

Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma

Published:2017-11 Issue:6 Volume:55 Page:372-375
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Sakata Shinya,Saeki Sho,Sato Ryo,Ishizuka Shiho,Sasaki Jiichiro,Fujii Kazuhiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference10 articles.

1. Sarcomatoid carcinoma;Corrin,2004

2. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders;Presta;Cancer Res,1997

3. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

4. Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: avaperl (MO22089);Barlesi;J Clin Oncol,2013

5. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicpathologic and immunohistochemical study of 75 cases;Rossi;Am J Surg Pathol,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review;Translational Lung Cancer Research;2024-03

2. Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024;International Journal of Clinical Oncology;2022-01-29

3. A Two-year Surviving Case of Primary Spindle Cell Carcinoma of the Lung after Adjuvant Chemotherapy;Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association);2020

4. Lung spindle cell carcinoma harbouring a constitutively active epidermal growth factor receptor mutation;Respirology Case Reports;2018-12-10

5. Systemic therapy in non-conventional cancers of the larynx;Oral Oncology;2018-07